| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*
Ludwig-Boltzmann Institute for Cell Biology and Immunobiology of the Skin, Department of Dermatology, University of Münster, Münster, Germany; and
Ben May Institute for Cancer Research, University of Chicago, Chicago, IL 60637
Immunosuppression by UV light contributes significantly to the
induction of skin cancer by suppressing the cell-mediated immune
responses which control the development of carcinogenesis. The
B7/CD28-CTLA-4 signaling pathway provides costimulatory signals
essential for Ag-specific T cell activation. To investigate the role of
this pathway in photocarcinogenesis, we utilized transgenic (Tg) mice
which constitutively express CTLA-4Ig, a high-affinity CD28/CTLA-4
antagonist that binds to both B7-1 and B7-2. The transgene is driven by
a skin-specific promoter yielding high levels of CTLA-4Ig in the skin
and serum. Chronic UV exposure of CTLA-4Ig Tg mice resulted in
significantly reduced numbers of skin tumors, when compared to control
mice. In addition, Tg mice were resistant to UV-induced suppression of
delayed-type hypersensitivity responses to alloantigens. Most
importantly, upon stimulation with mitogens and alloantigens, T cells
isolated from CTLA-4Ig Tg mice produced significantly less IL-4 but
more IFN-
compared to control T cells, suggesting an impaired Th2
response and a relative increase of Th1-type immunity. Together, these
data show that overall B7 engagement directs immune responses toward
the Th2 pathway. Moreover, they point out the crucial role of Th1
immune reactions in the protection against
photocarcinogenesis.
This article has been cited by other articles:
|
|
 |
|
  M. M. Welsh, K. M. Applebaum, S. K. Spencer, A. E. Perry, M. R. Karagas, and H. H. Nelson CTLA4 Variants, UV-Induced Tolerance, and Risk of Non-Melanoma Skin Cancer Cancer Res., August 1, 2009; 69(15): 6158 - 6163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Loser, J. Apelt, M. Voskort, M. Mohaupt, S. Balkow, T. Schwarz, S. Grabbe, and S. Beissert IL-10 Controls Ultraviolet-Induced Carcinogenesis in Mice J. Immunol., July 1, 2007; 179(1): 365 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Loeser, K. Loser, M. S. Bijker, M. Rangachari, S. H. van der Burg, T. Wada, S. Beissert, C. J.M. Melief, and J. M. Penninger Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells J. Exp. Med., April 16, 2007; 204(4): 879 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Maeda, S. W. Schneider, M. Kojima, S. Beissert, T. Schwarz, and A. Schwarz Enhanced photocarcinogenesis in interleukin-12-deficient mice. Cancer Res., March 15, 2006; 66(6): 2962 - 2969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Loser, A. Scherer, M. B. W. Krummen, G. Varga, T. Higuchi, T. Schwarz, A. H. Sharpe, S. Grabbe, J. A. Bluestone, and S. Beissert An Important Role of CD80/CD86-CTLA-4 Signaling during Photocarcinogenesis in Mice J. Immunol., May 1, 2005; 174(9): 5298 - 5305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Klatt and M. Serrano Engineering cancer resistance in mice Carcinogenesis, May 1, 2003; 24(5): 817 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Beissert, D. Ruhlemann, T. Mohammad, S. Grabbe, A. El-Ghorr, M. Norval, H. Morrison, R. D. Granstein, and T. Schwarz IL-12 Prevents the Inhibitory Effects of cis-Urocanic Acid on Tumor Antigen Presentation by Langerhans Cells: Implications for Photocarcinogenesis J. Immunol., December 1, 2001; 167(11): 6232 - 6238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Rossiter, S. Beissert, C. Mayer, M. P. Schön, B. G. Wienrich, E. Tschachler, and T. S. Kupper Targeted Expression of bcl-2 to Murine Basal Epidermal Keratinocytes Results in Paradoxical Retardation of Ultraviolet- and Chemical-induced Tumorigenesis Cancer Res., May 1, 2001; 61(9): 3619 - 3626. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
